每年專案
個人檔案
學歷
- 2002-2007 Postdoctoral training in Hematology and Oncology, Mount Sinai School of Medicine, New York, USA
- 1997.09-2002.05 美國紐約市立大學Biology博士
- 1994.09-1997.07 美國紐約市立大學Biology碩士
- 1984.09-1988.06 國立中興大學植物病理學系學士
經歷
- 2018.02- 臺北醫學大學國際醫學研究碩士學位學程副教授
- 2018.02- 臺北醫學大學細胞治療與再生醫學國際博士學位副教授
- 2016.11-2017.10 臺北醫學大學國際醫學研究碩士學位學程副教授
- 2013.02- 臺北醫學大學醫學科學研究所副教授
- 2009.08-2013.07 臺北醫學大學醫學科學研究所助理教授
- 2009.02-2009.07 中山醫學大學微生物免疫研究所助理教授
- 2007.10-2008.10 Research Associate, Hematology and Oncology/Medicine, Mount Sinai School of Medicine, New York, USA
- 1994-2008 Postdoctoral Fellow, Hematology and Oncology/Medicine, Mount Sinai School of Medicine, New York, USA
- 1994-2001 Adjunct Lecturer, Biology, Queens College, City University of New York
獎項
- 2007 Travel Award, ASH 50th Annual Meeting, San Diego, CA
研究興趣
- Leukocyte trafficking, Cancer biology, Wound healing, Traumatic brain injury
指紋
查看啟用 Jungshan Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
- 1 類似的個人檔案
網路
國家/地區層面的近期外部共同作業。按一下圓點深入探索詳細資料，或
專案
- 16 已完成
-
乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估-α9尼古丁受體於小鼠模式探討致癌機制與奈米藥物之臨床前試驗評估(3/3)
8/1/19 → 7/31/20
研究計畫: A - 政府部門 › b - 科技部
-
乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估-α9尼古丁受體於小鼠模式探討致癌機制與奈米藥物之臨床前試驗評估(2/3)
8/1/18 → 8/1/19
研究計畫: A - 政府部門 › b - 科技部
-
乳癌細胞尼古丁受體表現與新穎抗體奈米藥物之臨床前試驗評估-α9尼古丁受體於小鼠模式探討致癌機制與奈米藥物之臨床前試驗評估(1/3)
8/1/17 → 7/31/18
研究計畫: A - 政府部門 › b - 科技部
-
-
-
Nicotine exhausts CD8+ T cells against tumor cells through increasing miR-629-5p to repress IL2RB-mediated granzyme B expression
Cheng, C. C., Lin, H. C., Chiang, Y. W., Chang, J., Sie, Z. L., Yang, B. L., Lim, K. H., Peng, C. L., Ho, A. S. & Chang, Y. F., 五月 2021, 於: Cancer Immunology, Immunotherapy. 70, 5, p. 1351-1364 14 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
-
A novel microchip technique for quickly identifying nanogranules in an aqueous solution by transmission electron microscopy: Imaging of platelet granules
Trang, N. T. T., Chang, J., Chen, W. A., Chen, C. C., Chen, H. M., Chang, C. C. & Fong, T. H., 七月 2020, 於: Applied Sciences (Switzerland). 10, 14, 4946.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019
GBD 2019 Demographics Collaborators, 十月 17 2020, 於: The Lancet. 396, 10258, p. 1160-1203 44 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取64 引文 斯高帕斯（Scopus） -
Prognostic and clinical implications of WNK lysine deficient protein kinase 1 expression in patients with hepatocellular carcinoma
Ho, Y. J., Chang, J., Yeh, K. T., Gong, Z., Lin, Y. M. & Lu, J. W., 九月 2020, 於: In Vivo. 34, 5, p. 2631-2640 10 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取1 引文 斯高帕斯（Scopus） -
Reduction of Au3+to distinctive Au-based materials by amphiphilic sodium dodecylbenzenesulfonate
Hsu, Y. T., Chen, H. F., Lin, W. J., Chang, J. & Mai, F. D., 十一月 19 2020, 於: RSC Advances. 10, 69, p. 42116-42119 4 p.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取
資料集
-
MOESM11 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Chang, Y. (Contributor), Lim, K. (Contributor), Chiang, Y. (Contributor), Sie, Z. (Contributor), Chang, J. (Contributor), Ho, A. (Contributor) & Cheng, C. (Contributor), Unknown Publisher, 十月 16 2019
DOI: 10.6084/m9.figshare.9993542.v1, https://springernature.figshare.com/articles/MOESM11_of_STAT3_induces_G9a_to_exacerbate_HER3_expression_for_the_survival_of_epidermal_growth_factor_receptor-tyrosine_kinase_inhibitors_in_lung_cancers/9993542/1
資料集: Dataset
-
MOESM6 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Chang, Y. (Contributor), Lim, K. (Contributor), Chiang, Y. (Contributor), Sie, Z. (Contributor), Chang, J. (Contributor), Ho, A. (Contributor) & Cheng, C. (Contributor), Unknown Publisher, 十月 16 2019
DOI: 10.6084/m9.figshare.9993584.v1, https://springernature.figshare.com/articles/MOESM6_of_STAT3_induces_G9a_to_exacerbate_HER3_expression_for_the_survival_of_epidermal_growth_factor_receptor-tyrosine_kinase_inhibitors_in_lung_cancers/9993584/1
資料集: Dataset
-
MOESM10 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Chang, Y. (Contributor), Lim, K. (Contributor), Chiang, Y. (Contributor), Sie, Z. (Contributor), Chang, J. (Contributor), Ho, A. (Contributor) & Cheng, C. (Contributor), Unknown Publisher, 十月 16 2019
DOI: 10.6084/m9.figshare.9993536.v1, https://springernature.figshare.com/articles/MOESM10_of_STAT3_induces_G9a_to_exacerbate_HER3_expression_for_the_survival_of_epidermal_growth_factor_receptor-tyrosine_kinase_inhibitors_in_lung_cancers/9993536/1
資料集: Dataset
-
MOESM7 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Chang, Y. (Contributor), Lim, K. (Contributor), Chiang, Y. (Contributor), Sie, Z. (Contributor), Chang, J. (Contributor), Ho, A. (Contributor) & Cheng, C. (Contributor), Unknown Publisher, 十月 16 2019
DOI: 10.6084/m9.figshare.9993590.v1, https://springernature.figshare.com/articles/MOESM7_of_STAT3_induces_G9a_to_exacerbate_HER3_expression_for_the_survival_of_epidermal_growth_factor_receptor-tyrosine_kinase_inhibitors_in_lung_cancers/9993590/1
資料集: Dataset
-
MOESM12 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Chang, Y. (Contributor), Lim, K. (Contributor), Chiang, Y. (Contributor), Sie, Z. (Contributor), Chang, J. (Contributor), Ho, A. (Contributor) & Cheng, C. (Contributor), Unknown Publisher, 十月 16 2019
DOI: 10.6084/m9.figshare.9993545.v1, https://springernature.figshare.com/articles/MOESM12_of_STAT3_induces_G9a_to_exacerbate_HER3_expression_for_the_survival_of_epidermal_growth_factor_receptor-tyrosine_kinase_inhibitors_in_lung_cancers/9993545/1
資料集: Dataset